Cargando…

The avian coronavirus spike protein

Avian coronaviruses of the genus Gammacoronavirus are represented by infectious bronchitis virus (IBV), the coronavirus of chicken. IBV causes a highly contagious disease affecting the respiratory tract and, depending on the strain, other tissues including the reproductive and urogenital tract. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wickramasinghe, I.N. Ambepitiya, van Beurden, S.J., Weerts, E.A.W.S., Verheije, M.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114429/
https://www.ncbi.nlm.nih.gov/pubmed/25451062
http://dx.doi.org/10.1016/j.virusres.2014.10.009
_version_ 1783513884398714880
author Wickramasinghe, I.N. Ambepitiya
van Beurden, S.J.
Weerts, E.A.W.S.
Verheije, M.H.
author_facet Wickramasinghe, I.N. Ambepitiya
van Beurden, S.J.
Weerts, E.A.W.S.
Verheije, M.H.
author_sort Wickramasinghe, I.N. Ambepitiya
collection PubMed
description Avian coronaviruses of the genus Gammacoronavirus are represented by infectious bronchitis virus (IBV), the coronavirus of chicken. IBV causes a highly contagious disease affecting the respiratory tract and, depending on the strain, other tissues including the reproductive and urogenital tract. The control of IBV in the field is hampered by the many different strains circulating worldwide and the limited protection across strains due to serotype diversity. This diversity is believed to be due to the amino acid variation in the S1 domain of the major viral attachment protein spike. In the last years, much effort has been undertaken to address the role of the avian coronavirus spike protein in the various steps of the virus’ live cycle. Various models have successfully been developed to elucidate the contribution of the spike in binding of the virus to cells, entry of cell culture cells and organ explants, and the in vivo tropism and pathogenesis. This review will give an overview of the literature on avian coronavirus spike proteins with particular focus on our recent studies on binding of recombinant soluble spike protein to chicken tissues. With this, we aim to summarize the current understanding on the avian coronavirus spike's contribution to host and tissue predilections, pathogenesis, as well as its role in therapeutic and protective interventions.
format Online
Article
Text
id pubmed-7114429
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71144292020-04-02 The avian coronavirus spike protein Wickramasinghe, I.N. Ambepitiya van Beurden, S.J. Weerts, E.A.W.S. Verheije, M.H. Virus Res Article Avian coronaviruses of the genus Gammacoronavirus are represented by infectious bronchitis virus (IBV), the coronavirus of chicken. IBV causes a highly contagious disease affecting the respiratory tract and, depending on the strain, other tissues including the reproductive and urogenital tract. The control of IBV in the field is hampered by the many different strains circulating worldwide and the limited protection across strains due to serotype diversity. This diversity is believed to be due to the amino acid variation in the S1 domain of the major viral attachment protein spike. In the last years, much effort has been undertaken to address the role of the avian coronavirus spike protein in the various steps of the virus’ live cycle. Various models have successfully been developed to elucidate the contribution of the spike in binding of the virus to cells, entry of cell culture cells and organ explants, and the in vivo tropism and pathogenesis. This review will give an overview of the literature on avian coronavirus spike proteins with particular focus on our recent studies on binding of recombinant soluble spike protein to chicken tissues. With this, we aim to summarize the current understanding on the avian coronavirus spike's contribution to host and tissue predilections, pathogenesis, as well as its role in therapeutic and protective interventions. Elsevier B.V. 2014-12-19 2014-10-17 /pmc/articles/PMC7114429/ /pubmed/25451062 http://dx.doi.org/10.1016/j.virusres.2014.10.009 Text en Copyright © 2014 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wickramasinghe, I.N. Ambepitiya
van Beurden, S.J.
Weerts, E.A.W.S.
Verheije, M.H.
The avian coronavirus spike protein
title The avian coronavirus spike protein
title_full The avian coronavirus spike protein
title_fullStr The avian coronavirus spike protein
title_full_unstemmed The avian coronavirus spike protein
title_short The avian coronavirus spike protein
title_sort avian coronavirus spike protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114429/
https://www.ncbi.nlm.nih.gov/pubmed/25451062
http://dx.doi.org/10.1016/j.virusres.2014.10.009
work_keys_str_mv AT wickramasingheinambepitiya theaviancoronavirusspikeprotein
AT vanbeurdensj theaviancoronavirusspikeprotein
AT weertseaws theaviancoronavirusspikeprotein
AT verheijemh theaviancoronavirusspikeprotein
AT wickramasingheinambepitiya aviancoronavirusspikeprotein
AT vanbeurdensj aviancoronavirusspikeprotein
AT weertseaws aviancoronavirusspikeprotein
AT verheijemh aviancoronavirusspikeprotein